Keyphrases
Hemophilia
100%
Hemophilia B
78%
Factor 9
75%
Bleeding
61%
Pediatric
39%
Unfractionated Heparin
39%
Bleeding Disorders
34%
X-linked
31%
Plasma Factors
31%
Inhibitory Antibody
31%
Treatment-related
29%
Pediatric Population
29%
Inhibitor Development
26%
Anaphylaxis
26%
Recurrent Bleeding
26%
Postsurgical
26%
Oral Tissues
26%
Soft-tissue Bleeding
26%
Intramuscular Hemorrhage
26%
Severe Haemophilia A
22%
Partial Thromboplastin Time
22%
Anti-FXa
22%
Observational Cohort Study
22%
Gene Therapy
21%
F9 Gene
19%
Selective Immunoglobulin M Deficiency
19%
Thrombotic
19%
Clotting Disorders
19%
Cutaneous Lymphoproliferative Disorders
19%
IgA Deficiency
19%
Consumptive Coagulopathy
19%
Newly Diagnosed
19%
Kaposiform Lymphangiomatosis
19%
Lymphomatoid Papulosis
19%
Dose Capping
19%
Subhyaloid Hemorrhage
19%
MiR-1246
19%
Factor VIII Gene
19%
Heterogeneous Disorder
19%
Disease Analysis
19%
Anti-factor Xa
19%
Von Willebrand Disease
19%
Post-thrombotic Syndrome
19%
Genetic Determinants
19%
Small ncRNAs
19%
Efficacy Study
19%
Sickle Cell Disease
19%
Haemophilia with Inhibitors
19%
Expression Profiling
19%
Factor Level
19%
Medicine and Dentistry
Bleeding
86%
Haemophilia B
59%
Haemophilia A
49%
Factor IX
44%
Pediatrics
43%
Disseminated Intravascular Coagulation
39%
Patient with Hemophilia
33%
Quality of Life
33%
Hemostat
29%
Diseases
27%
Anaphylaxis
23%
Lymphangiomatosis
19%
Immunoglobulin M Deficiency
19%
Cohort Study
19%
Coagulopathy
19%
Unruptured Intracranial Aneurysm
19%
Capping Phenomenon
19%
Heparin
19%
Post-Thrombotic Syndrome
19%
Sickle-Cell Disease
19%
Body Weight
19%
Aneurysm
19%
Evans Syndrome
19%
Intracranial Aneurysm
19%
Efficacy Study
19%
Von Willebrand Disease
19%
Lymphoproliferative Disease
19%
Tranexamic Acid
19%
Menorrhagia
19%
Arm
19%
Pericardial Fluid
19%
Thrombosis
19%
Factor XI
19%
Blood Clotting Factor 8
16%
Plasma Factor
15%
Bleeding Disorder
15%
Immunological Tolerance
14%
Lymphomatoid Papulosis
13%
Pleura Effusion
13%
Antifibrinolytic
12%
Oral
12%
Rib Resection
11%
Anticoagulation
11%
Magnetic Resonance Angiography
11%
Fibrinolytic Therapy
11%
Magnetic Resonance Imaging
11%
Bleeding Diathesis
9%
Blood Clotting Factor 9 Concentrate
8%
Gene Therapy
8%
Visual Impairment
7%